Dusan Ruzic
Univerzitet u Beogradu
H-index: 9
Europe-Serbia
Top articles of Dusan Ruzic
Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer
2023/11/3
INVITED LECTURES
Journal of Radiation and Cancer Research
2018/1/1
Screening of naphthalimides as antimetastatic agents
2023/3/16
Correlating basal gene expression across chemical sensitivity data to screen for novel synergistic interactors of HDAC inhibitors in pancreatic carcinoma
Pharmaceuticals
2023/2/14
Discovery of novel HDAC inhibitors for therapy of triple-negative breast cancer–preclinical study
6th Congress of the Serbian AssociaƟ on for Cancer Research (SDIR)
2023
Towards the multitarget HDAC Inhibitors for the treatment of pancreatic carcinoma by joining the drug synergy predictions and the molecular modeling
10th IAPC Meeting Tenth World Conference on Physico-Chemical Methods in Drug Discovery & Sixth World Conference on ADMET and DMPK Belgrade, Serbia, September 4-6
2023
Discovery of novel small molecule inhibitors of HDAC6 that suppress liver fibrosis
Journal of Hepatology
2023
Dual LSD1 and HDAC6 inhibition induces doxorubicin sensitivity in acute myeloid leukemia cells
Cancers
2022/12/6
Discovery of 1-benzhydryl-piperazine-based HDAC inhibitors with anti-breast cancer activity: synthesis, molecular modeling, in vitro and in vivo biological evaluation
Pharmaceutics
2022/11/25
Novel protocol for enhanced sampling of binding pocket dynamics and its integration into the sirtuin 2 inhibitors virtual screening campaign
Archives of Pharmacy
2022/10/12
Racionalni dizajn, sinteza i in vitro ispitivanja selektivnih inhibitora histon deacetilaze 6
Универзитет у Београду
2022/6/9
Anticancer evaluation of the selected tetrahydropyrimidines: 3D-QSAR, cytotoxic activities, mechanism of action, DNA, and BSA interactions
Journal of Molecular Structure
2022/6/5
Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket Dynamics
Journal of Chemical Information and Modeling
2022/4/25
Design of Dual COX-2 and 5-LOX Inhibitors with Iron-Chelating Properties Using Structure-Based and Ligand-Based Methods
Letters in Drug Design & Discovery
2022/4/1
Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studies
Future Medicinal Chemistry
2022/4/1
Targeting histone deacetylases: opportunities for cancer treatment and chemoprevention
2022/1/16
Dusan Ruzic
H-Index: 5
Katarina Nikolic
H-Index: 17
Design of novel dual COX 2 and 5 LOX inhibitors using quantitative structure activity relationships analysis
MedChem 2022, XI Paul Ehrlich Euro-PhD Network, Barcelona, July 14th-16th 2022, Book of Abstracts
2022
Epigenetic drug discovery: fragment-based drug design of novel 1-benzhydryl-piperazine derivatives as selective histone deacetylase 6 inhibitors
2022
Bistable photoswitch allows in vivo control of hematopoiesis
ACS central science
2021/12/22
